Discovery Loop Platform or Owner
Discovery Loop
This choice determines whether Discovery Loop becomes the picks and shovels provider for autonomous R&D or a direct owner of scientific upside. A software only model means selling subscriptions, compute usage, and implementation work to many labs, which is easier to scale and keeps capital needs lower. Adding royalties, milestone payments, or shared IP can make each successful program far more valuable, but it also pulls the company closer to the economics and delivery burden of a discovery partner.
-
The clean software path is already visible in the product. The system takes a research goal, writes and runs many experiment branches, scores results, and chooses the next tests. That lends itself to charging for platform access plus compute, much like a high end R&D operating system rather than a drug or materials company.
-
The main reason to move downstream is that the biggest value often sits in the winning asset, not the workflow tool. Lila is pursuing that fuller stack by pairing scientific agents with owned lab infrastructure and proprietary data, while Benchling is expanding from record keeping into orchestration and analysis to control more of the design make test analyze loop.
-
A hybrid model is the practical middle ground. Discovery Loop can stay asset light by using external CROs, biofoundries, and cloud infrastructure for execution, then attach selective royalties or milestone economics only where its system materially drives the outcome. That captures upside without fully turning into a contract research organization.
The likely endpoint is a blended model, broad software revenue for reach, plus outcome based economics in a small number of high value programs. If Discovery Loop proves it can repeatedly improve hit rates or shorten research cycles, customers will accept shared economics, and the company can expand from orchestration software into a toll collector on the discoveries its system helps create.